- Home
- Labeler Index
- Novartis Pharmaceuticals Corporation
- 0078-0825
- NDC Crossover: 0078-0825 Sandostatin Lar Depot
NDC Crossover 0078-0825 Sandostatin Lar Depot
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 0078-0825 – Sandostatin Lar Depot, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Sandostatin Lar Depot
- OR Generic name: Octreotide Acetate
- AND the same Administration Route:
- OR Dosage Form: kit
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0078-0811 | Sandostatin Lar Depot | Octreotide Acetate | Kit | Novartis Pharmaceuticals Corporation | Human Prescription Drug | |
0078-0818 | Sandostatin Lar Depot | Octreotide Acetate | Kit | Novartis Pharmaceuticals Corporation | Human Prescription Drug | |
0480-9257 | Octreotide Acetate | Octreotide Acetate | Kit | Intramuscular | Teva Pharmaceuticals, Inc. | Human Prescription Drug |
0480-9259 | Octreotide Acetate | Octreotide Acetate | Kit | Intramuscular | Teva Pharmaceuticals, Inc. | Human Prescription Drug |
0480-9262 | Octreotide Acetate | Octreotide Acetate | Kit | Intramuscular | Teva Pharmaceuticals, Inc. | Human Prescription Drug |